China-Hospital-Deposit-Guarantee
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Corporate Information
THIS DOCUMENT IS IN DRAFT FORM. THE INFORMATION CONTAINED HEREIN IS INCOMPLETE AND IS SUBJECT TO CHANGE. THIS DOCUMENT MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. CORPORATE INFORMATION Head Office, Registered Office and No. 177-1, Chuangxin Road Principal Place of Business in the PRC Hunnan District Shenyang Liaoning Province the PRC Principal Place of Business in Hong Kong 40/F, Dah Sing Financial Centre 248 Queen’s Road East Wanchai Hong Kong Company’s Website www.neusoftmedical.com (information on this website does not form part of this Document) Joint Company Secretaries Mr. LI Feng (李峰) No. 177-1, Chuangxin Road Hunnan District Shenyang Liaoning Province the PRC Mr. CHENG Ching Kit (鄭程傑) (ACS, ACG) 40/F, Dah Sing Financial Centre 248 Queen’s Road East Wanchai Hong Kong Authorized Representatives Mr. WU Shaojie (武少傑) No. 177-1, Chuangxin Road Hunnan District Shenyang Liaoning Province the PRC Mr. CHENG Ching Kit (鄭程傑) (ACS, ACG) 40/F, Dah Sing Financial Centre 248 Queen’s Road East Wanchai Hong Kong –91– THIS DOCUMENT IS IN DRAFT FORM. THE INFORMATION CONTAINED HEREIN IS INCOMPLETE AND IS SUBJECT TO CHANGE. THIS DOCUMENT MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. CORPORATE INFORMATION Audit Committee Dr. YAO Haixin (姚海鑫)(Chairman) Dr. CHOI Koon Shum (蔡冠深) Mr. ZHAO JOHN HUAN (趙令歡) Dr. CHEN LIAN YONG (陳連勇) Dr. FENG Xiaoyuan (馮曉源) Remuneration and Appraisal Committee Dr. FENG Xiaoyuan (馮曉源) (Chairman) Mr. WU Shaojie (武少傑) Dr. CHEN LIAN YONG (陳連勇) Dr. -
Name of Recognized Medical Schools (Foreign)
1 Name of Recognized Medical Schools (Foreign) Expired AUSTRALIA 1 School of Medicine, Faculty of Heath, University of Tasmania, Tasmania, Australia (5 years Program) 9 Jan Main Affiliated Hospitals 2021 1. Royal H obart Hospital 2. Launceston Gen Hospital 3. NWest Region Hospital 2 Melbourne Medical School, University of Melbourne, Victoria, Australia (4 years Program) 1 Mar Main Affiliated Hospitals 2022 1. St. Vincent’s Public Hospital 2. Epworth Hospital Richmond 3. Austin Health Hospital 4. Bendigo Hospital 5. Western Health (Sunshine, Footscray & Williamstown) 6. Royal Melbourne Hospital Affiliated Hospitals 1. Pater MacCallum Cancer Centre 2. Epworth Hospital Freemasons 3. The Royal Women’s Hospital 4. Mercy Hospital for Women 5. The Northern Hospital 6. Goulburn Valley Health 7. Northeast Health 8. Royal Children’s Hospital 3 School of Medicine and Public Health, University of Newcastle, New South Wales, Australia (5 years Program) 3 May Main Affiliated Hospitals 2022 1.Gosford School 2. John Hunter Hospital Affiliated Hospitals 1. Wyong Hospital 2. Calvary Mater Hospital 3. Belmont Hospital 4. Maitland Hospital 5. Manning Base Hospital & University of Newcastle Department of Rural Health 6. Tamworth Hospital 7. Armidale Hospital 4 Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia (4 and 5 years Program) 8 Nov Main Affiliated Hospitals 1. Eastern Health Clinical School: EHCS 5 Hospitals 2022 2. Southern School for Clinical Sciences: SCS 5 Hospitals 3. Central Clinical School จ ำนวน 6 Hospitals 4. School of Rural Health จ ำนวน 7 Hospital 5 Sydney School of Medicine (Sydney Medical School), Faculty of Medicine and Health, University of Sydney, Australia 12 Dec (4 years Program) 2023 2 Main Affiliated Hospitals 1. -
Association Between Ages and Clinical Characteristics and Outcomes of Coronavirus Disease 2019
Early View Research letter Association Between Ages and Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Yang Liu, Bei Mao, Shuo Liang, Jia-wei Yang, Hai-wen Lu, Yan-hua Chai, Lan Wang, Li Zhang, Qiu- hong Li, Lan Zhao, Yan He, Xiao-long Gu, Xiao-bin Ji, Li Li, Zhi-jun Jie, Qiang Li, Xiang-yang Li, Hong-zhou Lu, Wen-hong Zhang, Yuan-lin Song, Jie-ming Qu, Jin-fu Xu Please cite this article as: Liu Y, Mao B, Liang S, et al. Association Between Ages and Clinical Characteristics and Outcomes of Coronavirus Disease 2019. Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.01112-2020). This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Copyright ©ERS 2020. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. Association Between Ages and Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Yang Liu, MD1#, Bei Mao, MD1#, Shuo Liang, MD1#, Jia-wei Yang1#, Hai-wen Lu, MD1#, Yan-hua Chai, MD1#, Lan Wang, MD2, Li Zhang, MD1, Qiu-hong Li, MD1, Lan Zhao, MD1, Yan He, RN1, Xiao-long Gu, MD3, Xiao-bin Ji, MD4, Li Li, MD5, Zhi-jun Jie, MD6, Qiang Li, MD7, Xiang-yang Li, MD8, Hong-zhou Lu, DPH9, Wen-hong Zhang, MD10, Yuan-lin Song, MD11, Jie-ming Qu, MD12* and Jin-fu Xu, MD1* on behalf of the Shanghai Clinical Treatment Experts Group for COVID-19 Institutional affiliations: 1. -
A Systematic Review and Meta-Analysis Jing Zhang,1 Yue-Li Zhang,2 Kai-Xiang Ma,3 Jie-Ming Qu2
Lung cancer Thorax: first published as 10.1136/thoraxjnl-2012-202592 on 15 January 2013. Downloaded from ORIGINAL ARTICLE Efficacy and safety of adjunctive anticoagulation in patients with lung cancer without indication for anticoagulants: a systematic review and meta-analysis Jing Zhang,1 Yue-Li Zhang,2 Kai-Xiang Ma,3 Jie-Ming Qu2 ▸ Additional material is ABSTRACT published online only. To view Background Patients with lung cancer are at high risk Key messages please visit the journal online (http://dx.doi.org/10.1136/ of venous thromboembolism (VTE), and VTE predicts a thoraxjnl-2012-202592). poor prognosis. Anticoagulation therefore might be beneficial for these patients. It is not clear whether 1Department of Pulmonary What is the key question? Medicine, Zhongshan Hospital, anticoagulants could improve survival and other ▸ Can anticoagulants improve survival and other Shanghai Medical College, outcomes in patients with lung cancer with no indication outcomes in patients with lung cancer without Fudan University, Shanghai, for anticoagulation. indication for anticoagulation? China Methods We searched the Web of Science, Medline, 2Department of Pulmonary What is the bottom line? Medicine, Huadong Hospital, EMBASE and Cochrane databases for relevant studies. Two reviewers evaluated the studies and extracted data ▸ This meta-analysis revealed a long-term Shanghai Medical College, fi Fudan University, Shanghai, independently. The primary outcomes were 1-year survival bene t in addition to reduced China survival and incidence of VTE. Pooled risk ratios (RR) incidence of venous thromboembolism from 3Department of Pulmonary anticoagulation treatment in patients with lung ’ were calculated using control as a reference group and Medicine, Fuyuan People s fi cancer who have no clinical indication for Hospital, Yunnan Province, signi cance was determined by the Z test. -
Fu Shou Yuan International Group Limited 福壽園國際集團有限公司 (Incorporated in the Cayman Islands with Limited Liability) (Stock Code: 1448)
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Fu Shou Yuan International Group Limited 福壽園國際集團有限公司 (incorporated in the Cayman Islands with limited liability) (Stock Code: 1448) VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION AGREEMENTS This is a voluntary announcement made by Fu Shou Yuan International Group Limited (the “Company”, together with its subsidiaries, the “Group”) for keeping the shareholders of the Company and potential investors informed of the latest business development of the Group. The board of directors (the “Board”) of the Company is pleased to announce that, on December 19, 2014, the Company entered into strategic cooperation agreements with each of the People’s Government of Hunnan District of Shenyang City* (瀋陽市渾南區人民政府)(“Shenyang City Hunnan District Government”) (“Shenyang Strategic Cooperation”) and the People’s Government of Jinzhou City* in Liaoning Province (遼寧省錦州市人民政府)(“Jinzhou City Government”) (“Jinzhou Strategic Cooperation”), in relation to the further development and cooperation in the death care services industry in the respective cities. SHENYANG STRATEGIC COOPERATION Under the Shenyang Strategic Cooperation, among other things, the Shenyang City Hunnan District Government will source potential funeral services development projects for the Company, which they will in return (i) provide due diligence support and feasibility analysis (ii) source investment funding and introduce high-technology funeral equipments and (iii) structure innovative service system, implement the Company’s business objectives and management expertise. -
Shengjing Bank Co., Ltd.* (A Joint Stock Company Incorporated in the People's Republic of China with Limited Liability) Stock Code: 02066 Annual Report Contents
Shengjing Bank Co., Ltd.* (A joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 02066 Annual Report Contents 1. Company Information 2 8. Directors, Supervisors, Senior 68 2. Financial Highlights 4 Management and Employees 3. Chairman’s Statement 7 9. Corporate Governance Report 86 4. Honours and Awards 8 10. Report of the Board of Directors 113 5. Management Discussion and 9 11. Report of the Board of Supervisors 121 Analysis 12. Social Responsibility Report 124 5.1 Environment and Prospects 9 13. Internal Control 126 5.2 Development Strategies 10 14. Independent Auditor’s Report 128 5.3 Business Review 11 15. Financial Statements 139 5.4 Financial Review 13 16. Notes to the Financial Statements 147 5.5 Business Overview 43 17. Unaudited Supplementary 301 5.6 Risk Management 50 Financial Information 6. Significant Events 58 18. Organisational Chart 305 7. Change in Share Capital and 60 19. The Statistical Statements of All 306 Shareholders Operating Institution of Shengjing Bank 20. Definition 319 * Shengjing Bank Co., Ltd. is not an authorised institution within the meaning of the Banking Ordinance (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorised to carry on banking and/or deposit-taking business in Hong Kong. COMPANY INFORMATION Legal Name in Chinese 盛京銀行股份有限公司 Abbreviation in Chinese 盛京銀行 Legal Name in English Shengjing Bank Co., Ltd. Abbreviation in English SHENGJING BANK Legal Representative ZHANG Qiyang Authorised Representatives ZHANG Qiyang and ZHOU Zhi Secretary to the Board of Directors ZHOU Zhi Joint Company Secretaries ZHOU Zhi and KWONG Yin Ping, Yvonne Registered and Business Address No. -
Table of Codes for Each Court of Each Level
Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115 -
CMN / EA International Provider Network HOSPITALS/CLINICS
CMN / EA International Provider Network HOSPITALS/CLINICS As of March 2010 The following document is a list of current providers. The CMN/EA International Provider Network spans approximately 200 countries and territories worldwide with over 2000 hospitals and clinics and over 6000 physicians. *Please note that the physician network is comprised of private practices, as well as physicians affiliated with our network of hospitals and clinics. Prior to seeking treatment, Members must call HCCMIS at 1-800-605-2282 or 1-317-262-2132. A designated member of the Case Management team will coordinate all healthcare services and ensure that direct billing arrangements are in place. Please note that although a Provider may not appear on this list, it does not necessarily mean that direct billing cannot be arranged. In case of uncertainty, it is advised Members call HCCMIS. CMN/EA reserves the right, without notice, to update the International Provider Network CMN/EA International Provider Network INTERNATIONAL PROVIDERS: HOSPITALS/CLINICS FacilitY Name CitY ADDRess Phone NUMBERS AFGHanistan DK-GERman MedicaL DiagnOstic STReet 66 / HOUse 138 / distRict 4 KABUL T: +93 (0) 799 13 62 10 CenteR ZOne1 ALBania T: +355 36 21 21 SURgicaL HOspitaL FOR ADULts TIRana F: +355 36 36 44 T: +355 36 21 21 HOspitaL OF InteRnaL Diseases TIRana F: +355 36 36 44 T: +355 36 21 21 PaediatRic HOspitaL TIRana F: +355 36 36 44 ALGERia 4 LOT. ALLIOULA FOdiL T: +213 (21) 36 28 28 CLiniQUE ChahRAZed ALgeR CHÉRaga F: +213 (21) 36 14 14 4 DJenane AchaBOU CLiniQUE AL AZhaR ALgeR -
Annual Report Is Published
Contents 1. Company Information 2 8. Directors, Supervisors, Senior 73 2. Financial Highlights 4 Management and Employees 3. Chairman’s Statement 7 9. Corporate Governance Report 90 4. Honours and Awards 8 10. Report of the Board of Directors 117 5. Management Discussion and 9 11. Report of the Board of Supervisors 125 Analysis 12. Social Responsibility Report 128 5.1 Analysis of Overall 9 13. Internal Control 130 Operations 14. Independent Auditor’s Report 132 5.2 Financial Review 11 15. Financial Statements 142 5.3 Business Overview 44 16. Notes to the Financial Statements 150 5.4 Risk Management 52 17. Unaudited Supplementary 302 5.5 Environmental Outlook and 58 Financial Information Development Strategy 18. Organisational Chart 306 6. Significant Events 60 19. The Statistical Statements of All 307 7. Change in Share Capital and 64 Operating Institution of Shengjing Shareholders Bank 20. Definition 323 * Shengjing Bank Co., Ltd. is not an authorised institution within the meaning of the Banking Ordinance (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorised to carry on banking and/or deposit-taking business in Hong Kong. Chapter 1 Company Information COMPANY INFORMATION Legal Name in Chinese 盛京銀行股份有限公司 Abbreviation in Chinese 盛京銀行 Legal Name in English Shengjing Bank Co., Ltd. Abbreviation in English SHENGJING BANK Legal Representative QIU Huofa Authorised Representatives QIU Huofa and ZHOU Zhi Secretary to the Board of Directors ZHOU Zhi Joint Company Secretaries -
Vibration Control of a High-Rise Slender Structure with a Spring Pendulum Pounding Tuned Mass Damper
actuators Article Vibration Control of a High-Rise Slender Structure with a Spring Pendulum Pounding Tuned Mass Damper Qi Wang 1,2 , Hong-Nan Li 1,3 and Peng Zhang 4,* 1 School of Civil Engineering, Shenyang Jianzhu University, Hunnan District, Shenyang 110168, China; [email protected] (Q.W.); [email protected] (H.-N.L.) 2 Department of Road and Bridge Engineering, Liaoning Provincial College of Communications, Shenyang 110168, China 3 State Laboratory of Coastal and Offshore Engineering, Faculty of Infrastructure Engineering, Dalian University of Technology, Ganjingzi District, Dalian 116024, China 4 Institute of Road and Bridge Engineering, Dalian Maritime University, Dalian 116023, China * Correspondence: [email protected] Abstract: High-rise structures are normally tall and slender with a large height-width ratio. Under the strong seismic action, such a structure may experience violent vibrations and large deformation. In this paper, a spring pendulum pounding tuned mass damper (SPPTMD) system is developed to reduce the seismic response of high-rise structures. This SPPTMD system consists of a barrel limiter with the built-in viscoelastic material and a spring pendulum (SP). This novel type of tuned mass damper (TMD) relies on the internal resonance feature of the spring pendulum and the collision between the added mass and barrel limiter to consume the energy of the main structure. Based on the Hertz-damper model, the motion equation of the structure-SPPTMD system is derived. Further- more, a power transmission tower is selected to evaluate the vibration reduction performance of the Citation: Wang, Q.; Li, H.-N.; Zhang, SPPTMD system. -
Research Article Coordination and Coupling of Active and Passive Energy Optimization in Public Institutions: a Case Study of Hunnan District, Shenyang in China
Hindawi Mathematical Problems in Engineering Volume 2020, Article ID 5301842, 8 pages https://doi.org/10.1155/2020/5301842 Research Article Coordination and Coupling of Active and Passive Energy Optimization in Public Institutions: A Case Study of Hunnan District, Shenyang in China Shui Yu , Jianghui Yang, and Qixiang Gao School of Municipal and Environmental Engineering, Shenyang Jianzhu University, 110168 Shenyang, China Correspondence should be addressed to Shui Yu; [email protected] Received 26 September 2019; Revised 12 December 2019; Accepted 18 December 2019; Published 9 January 2020 Academic Editor: Carlo Renno Copyright © 2020 Shui Yu et al. 'is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Taking Hunnan District of Shenyang City as an example, this paper investigates 32 government agencies, 17 tertiary first-class hospitals, and 15 colleges and universities in Hunnan region and analyzes the energy consumption characteristics of three types of public institutions. 'rough the use of DeST energy consumption software to simulate the energy consumption of three types of public institutions, combined with the load density method to predict the total energy demand of hospitals, universities, and government agencies in Hunnan area and the MARKAL model coupling mechanism, the coupling model of active and passive energy suitable for public institutions is presented. According to the forecast results of energy demand, combined with the energy consumption structure and energy conversion efficiency, the energy supply of each subitem of the public institution was solved and the energy supply of the public institutions in Hunnan District was optimized in accordance with the relevant constraints. -
The Clinical Value of 18F-Fluoroestradiol in Assisting Individualized Treatment Decision in Dual Primary Malignancies
3965 Original Article The clinical value of 18F-fluoroestradiol in assisting individualized treatment decision in dual primary malignancies Ziyi Yang1,2,3#, Yizhao Xie4,5#, Cheng Liu1,2,3, Xin Liu4,5, Shaoli Song1,2,3, Yingjian Zhang1,2,3, Rui Ge6, Biyun Wang4,5, Zhongyi Yang1,2,3 1Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China; 2Center for Biomedical Imaging, Fudan University, Shanghai, China; 3Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China; 4Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; 5Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 6Department of General Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China Contributions: (I) Conception and design: Z Yang, Y Xie, R Ge, B Wang, Z Yang; (II) Administrative support: S Song, Y Zhang; (III) Provision of study materials or patients: Z Yang, Y Xie, Z Yang; (IV) Collection and assembly of data: Z Yang, Y Xie, Z Yang; (V) Data analysis and interpretation: Z Yang, Y Xie, C Liu, X Liu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Rui Ge. Department of General Surgery, Huadong Hospital Affiliated to Fudan University, 221 West Yan’an Road, Jingan District Shanghai 200040, China. Email: [email protected]; Biyun Wang. Department of Medical Oncology, Fudan University Shanghai Cancer Center, No. 270 Dong’an Road, Xuhui District, Shanghai 200032, China. Email: [email protected]; Zhongyi Yang. Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, No. 270 Dong’an Road, Xuhui District, Shanghai 200032, China.